Clinical Trial Update: Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study [Phase 3]

View source ↗

Summary

A randomized phase III trial evaluating lomustine with or without reirradiation for first progression of glioblastoma. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Lomustine (Lomustine)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: First Progression of Glioblastoma | Phase 3 | Status: RECRUITING